Histamine H3 Antagonists for Treatment of Cognitive Deficits in CNS Diseases

Rita Raddatz, Robert L. Hudkins(State Street (United States)), Ming Tao(Peking University)

Current Topics in Medicinal Chemistry

January 17, 2010

10.2174/156802610790411027

Cited by 74

Related Papers

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery

|ACS Chemical Neuroscience|2011|436

Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma

|Molecular Cancer|2024|309

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

|PubMed|2003|124

Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a Derivatives

|Journal of Medicinal Chemistry|1997|120

Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors

|Expert Opinion on Drug Discovery|2016|113